# Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

> **NCT06767982** · PHASE4 · COMPLETED · sponsor: **Ankara University** · enrollment: 160 (actual)

## Conditions studied

- Non Muscle Invasive Bladder Cancer

## Interventions

- **DRUG:** Bacillus Calmette-Guerin (BCG)

## Key facts

- **NCT ID:** NCT06767982
- **Lead sponsor:** Ankara University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06767982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06767982, "Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06767982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*